Note: Logos of drug companies are available in files to use as art.
Pharmacy -- Photo "story" on CVS ProCare specialty pharmacy stores in more than 30 cities that provids medications for patients with HIV/AIDS, cancer, organ transplants and other serious conditions.
Brain --New brain disorder tools results in new drugs -- Researchers have constructed a model of an axon, which they have used to reproduce a change in the axon's shape that is characteristic of neurodegenerative disorders. The model provides a new road to discovering new kinds of drugs for the treatment of these disorders. (600 words)
Bones -- Decitabine, a new drug undergoing Phase III efficacy trials, provides palliative therapy for patients with the bone marrow disease called Myelodysplastic Syndrome (MDS), according to a new study. MDS is a bone marrow disease of the elderly and one of the common geriatric blood-related cancers. -- (500 words)
Worm
-- A team of Howard Hughes Medical Institute (HHMI) researchers has hit paydirt
by plumbing the biochemical intricacies of a lowly soil-dwelling worm. Their
discovery has revealed a new target for drug therapy that may help alleviate
parasitic worm infections that afflict tens of millions of people worldwide.
(750 words)
Headlice -- (News2Use) -- The use or sale of lindane in California will soon become illegal. 345 words
Eyes --Clinical studies on three new drugs have shown their effectiveness in reducing vision loss from wet age related macular degeneration (AMD) in early clinical studies. AMD is the leading cause of legal blindness in the United States in adults over the age of 65. (350 words)
Lupus -- (News2Use) -- A new drug candidate may offer hope to the half million people in the United States and Europe suffering from lupus kidney disease. -- 347 words
TB -- Researchers at the Albert Einstein College of Medicine of Yeshiva University have synthesized chemicals that are up to 10 times more effective than isoniazid, the leading anti-tuberculosis drug. The finding could lead to badly needed new drugs for combating tuberculosis bacteria, which each year kill an estimated 2.4 million people worldwide (300 words).
Pfizer -- Commentary -- with Pfizer logo -- 260 words
Asthma -- D/R/A Group Inc. -- AstraZeneca's Pulmicort Respulesª (budesonide inhalation suspension) -- for use in children from 12 months to eight years of age -- are now available in the United States. -- 782 words
Asthma2 -- D/R/A Group Inc. -- 3M Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted approval for QVARª (beclomethasone dipropionate HFA) Inhalation Aerosol for the treatment of asthma.
Background -- Information on Clinical Research -- 1,348 words
Development -- It takes 12 years on average for an experimental drug to travel from lab to medicine chest. -- 600 words
Cholesterol -- news release from Novartis Pharmaceuticals Corporation announcing approval for Lescol XL. The drug provides effective management of all major lipid parameters for patients with a variety of lipid disorders that place them at risk for heart disease. -- 812 words
Cold Sores -- D/R/A Group Inc. -- Avanir Pharmaceuticals announced that the FDA has granted full marketing approval for docosanol 10% cream, a topical treatment for recurrent oral-facial herpes simplex infections, commonly known as cold sores or fever blisters. -- 496 words
Migraines -- FDA Newsnote -- The FDA Guide recently approved Depakote ER (divalproex [Image] sodium extended-release tablets), a once-a-day formulation for the prevention of migraine headaches in adults. 140 words
Diabetes -- FDA Newsnote -- Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) has approved Glucophage¨ XR (metformin HCl extended release tablets) for use as initial drug therapy for people with type 2 diabetes when diet and exercise are not enough. -- 462 words
Drugads -- An overwhelming majority of pharmacists in the United States object to drug companies advertising prescription medicines direct to consumers, according to the latest "Pharmacy Business News" Trends Survey. However, they also believe that Government will pave the way for more of it in the next 5 years. -- 1,158 words -- cartoon available
Newdrugs -- The FDA Drug Approvals monthly list. -- 1,630 words
Druglabeling -- The FDA has proposed that all systemic antibacterial drug products intended for human use contain additional labeling information about the emergence of drug-resistant bacterial strains. Over-prescribing and inappropriate use of antibiotics have contributed to a dramatic increase in drug-resistant bacterial infections. -- 356 words
MS -- FDA Newsnote -- FDA has approved Novantrone (mitoxantrone), an approved cancer drug, for treating patients with advanced or chronic Multiple Sclerosis. -- 370 words -- photo possible
Pepcid -- D/R/A Group Inc. -- FDA Approves Pepcid Complete (Calcium Carbonate, Magnesium Hydroxide) For Heartburn And Acid Indigestion -- 358 words
Drugprices -- Column from The Thinktank Institute: "the road to hell is paved with good intentions," an adage that applies "all too well" to the pharmaceutical debate -- 800 words
Prozac -- Column published in Sacramento Bee -- Recently we were reminded that pricey prescriptions for gramps and granny are not the gravest offense some drug companies are guilty of when Eli Lilly announced it was halting development of a new and improved version of Prozac, its top selling drug. -- 920 words -- mugshot of writer available
ThePill -- From Ladies Home Journal -- Some old misperceptions die hard. Take the Pill. -- 315 words
Teva -- From Reuters - Israel's Teva Pharmaceutical Industries receives final U.S. Food & Drug Administration approval to manufacture and market Doxazosin, the generic version of Pfizer Inc's cardiovascular/benign prostate hyperplasma drug, Cardura. -- 112 words
Altace -- From the D/R/A Group Inc. -- FDA Approves New Indication For Altace (Ramipril), To Reduce Risk of Stroke, Heart Attack -- 1,215 words
Aventis -- company press release -- Aventis Behring announces the successful results of its large, pivotal Phase I clinical trial for Recombumin20%. The trial was designed to assess the tolerability of Recombumin20% as a stabilizing component in pharmaceutical and biological products, such as vaccines, recombinant therapies and coatings for medical devices. -- 735 words
Women's Tylenol -- From the D/R/A Group -- The makers of Tylenol announced the national introduction of Women's Tylenol Menstrual Relief, their first product developed exclusively for women. -- 278 words
Colon test -- from Health News -- Americans who undergo a colonoscopy soon will have an alternative to the unpleasant preparation currently required before the test -- an oral laxetive in pill form approved by the Food and Drug Administration last month and is expected to reach pharmacies by early January. -- 586 words
Drug Plan -- A federal judge has blocked Maine's pioneering-law aimed at cutting the cost of prescriptions with the threat of price controls, saying it would probably be tossed out as unconstitutional. -- 264 words
Heartfail -- press release -- New data from the COPERNICUS trial presented today at the American Heart Association’s 73rd Annual Scientific Sessions in New Orleans showed that the beta blocking agent Coreg reduced the risk of death or hospitalization due to heart failure by nearly a third in patients with advanced stages of the disease who were already taking ACE-based therapy.-- 1,400 words
AIDS -- press release -- Dr. David Ho, head of the Aaron Diamond AIDS Research Center, Dr. Irvin Chen of the UCLA AIDS Institute, and Dr. Rafi Ahmed of the Emory Vaccine Center today announced a major initiative aimed at finding an AIDS Vaccine. -- mugshots available